Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease-First, Do No Harm

Emilie P Belley-Cote^{1

2}, John W Eikelboom^{1

2}

Affiliations

¹ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
² Population Health Research Institute, David Braley Cardiac, Vascular, and Stroke Research Institute, Hamilton, Ontario, Canada.

Free article

Comment

Emilie P Belley-Cote et al. JAMA Netw Open. 2020.

Free article

. 2020 Apr 1;3(4):e202237.

doi: 10.1001/jamanetworkopen.2020.2237.

Emilie P Belley-Cote^{1

2}, John W Eikelboom^{1

2}

¹ Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
² Population Health Research Institute, David Braley Cardiac, Vascular, and Stroke Research Institute, Hamilton, Ontario, Canada.

No abstract available

Comment on

Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis.
Randhawa MS, Vishwanath R, Rai MP, Wang L, Randhawa AK, Abela G, Dhar G. Randhawa MS, et al. JAMA Netw Open. 2020 Apr 1;3(4):e202175. doi: 10.1001/jamanetworkopen.2020.2175. JAMA Netw Open. 2020. PMID: 32250434 Free PMC article.